Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

X
Drug Profile

Methylthioninium chloride - PREXA SANTE

Alternative Names: PrexaBlu; Product-118; Sublingual Methylene blue

Latest Information Update: 28 Nov 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Prexa Sante
  • Class Antidementias; Antidotes; Antimalarials; Antiparkinsonians; Antiseptics; Antivirals; Diagnostic agents; Dimethylamines; Phenothiazines; Small molecules
  • Mechanism of Action Monoamine oxidase inhibitors; Synuclein inhibitors; Tau protein inhibitors; Virus replication inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported COVID 2019 infections

Most Recent Events

  • 28 Nov 2023 No recent reports of development identified for phase-I development in COVID-2019-infections in Mexico (SC)
  • 13 Apr 2021 PREXA SANTE announces intention to submit IND to the US FDA for COVID-2019 infections in 2021
  • 13 Apr 2021 PREXA SANTE plans a clinical trial for COVID-2019 infections in USA and other countries (SC) in 2021

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days